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capacity (31 ± 14% vs. 40 ± 14%, p = 0.02).We found a statistically
no signiﬁcant difference for the other functional features or HDL
properties between the groups. Conclusions: Small HDL particles,
low HDL phospholipid content and decreased cholesterol efﬂux
capacity were related to magnitude of subclinical atherosclerosis and
hypoalphalipoproteinemia in a primary care population.
doi:10.1016/j.bbacli.2015.05.039
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Whole-vessel remodeling critically determines lumen caliber in
vascular (patho)physiology and is reportedly redox-dependent. We
hypothesized that cell-surface pool of the endoplasmic reticulum
(ER) redox chaperone Protein Disulﬁde Isomerase-A1 (peri/epi-
cellular = pecPDI), known to support thrombosis, also regulates
disease-associated vascular architecture. In human coronary athero-
mas, PDI expression inversely correlated with constrictive remodel-
ing and plaque stability. In rabbit iliac artery overdistension model,
there was unusually high PDI upregulation (~25-fold vs. basal
14 days post-injury), involving both intracellular and pecPDI.
Silencing PDI by siRNA in vitro induced ER stress markers
upregulation and apoptosis (assessed by TUNEL assay). PDI knock-
down also upregulated proliferation marker PCNA and decreased
differentiation marker calponin-C. In contrast, pecPDI neutralization
with anti-PDI antibodies (PDIAb) did not enhance ER stress or
apoptosis. In vivo pecPDI neutralization with PDIAb-containing
perivascular gel from days 12–14 post-injury promoted ca. 25%
decrease in maximally dilated arteriographic vascular caliber and
corresponding whole-vessel circumference loss at optical coherence
tomography, without changing neointima, suggesting constrictive
remodeling. This was accompanied by decreased oxidant generation
and nitrogen oxide production. Constrictive remodeling was corrob-
orated by marked changes in collagen organization, switching from
circumferential to radial ﬁber orientation and to more rigid ﬁber
type. Cytoskeleton architecture was also disrupted, with loss of stress
ﬁber coherent organization and switch from thin to medium-
thickness actin ﬁbers, all leading to impaired viscoelastic ductility.
Total and PDI-associated expressions of beta1-integrin, as well as
cell-surface reduced beta1-integrin levels, were diminished after
PDIAb treatment, implicating beta1-integrin as a likely pecPDI target
during vessel repair. Integrin signaling is a master regulator of
mechanobiology connecting the extracellular matrix environment to
focal adhesion and actin-cytoskeleton. Indeed, FAK phosphorylation,
a downstream beta1-integrin effector, was decreased by PDIAb. Thus,
PDI is highly upregulated after injury and reshapes matrix and
cytoskeleton architecture to support an anticonstrictive remodeling
effect. Such ﬁndings suggest an important role for PDI in lumen
maintenance during vascular remodeling by regulation of mechano-
adaptive mechanisms.
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Introduction: Low levels of Vitamin D increase risk of cardiovas-
cular diseases. This study aims to assess the effects of vitamin D in an
experimental model of rabbits fed a diet enriched with fat/sucrose/
cholesterol (FSC). Methods: The rabbits were fed a chow enriched
with fat 10%/sucrose 40%/cholesterol 0.5% for three months and
thereafter, the chow were substituted for FSC with cholesterol 0.1%
or standard chow for more 3 months. The following groups were
formed: I — FSC 0.5/0.1%; GII — FSC 0.5/0.1% + Vit D 1000 IU/day;
GIII — FSC 0.5%/ standard chow (SC) and GIV — FSC 0.5%/ standard
chow+ 1000 IU of Vit D/day. In periods of 0, 3 and 6 months the
following parameters were evaluated: weight, lipid proﬁle and
serum glucose. After 6 months the animals were euthanized and
the aortas were removed for atheroma plaques analysis. Statistical
analysis was performed by Kruskal–Wallis non-parametric tests
followed by Dunn's test. Results: After 6 months, the following
values were observed, respectively, in groups I, II, III and IV: total
cholesterol (mg/dL):420 ± 128; 363 ± 119; 149 ± 136; 162 ± 132.
Triglycerides(mg/dL): 172 ± 58; 202 ± 79; 74 ± 24; 63 ± 13. Glu-
cose (mg/dL):97 ± 5; 92 ± 13; 100 ± 18; 106 ± 11. Plaques in
aorta(%): 83 ± 24,62; 84,64 ± 23,22; 15,38 ± 5,95; 24,11 ± 8,81.
Intima/media ratio in arch aorta: 2.98 ± 2.16; 2.57 ± 1.06; 2.74 ±
1.22; 1.35 ± 0.39*. Thoracic aorta: 2.13 ± 1.15; 1.80 ± 1.05; 1.54 ±
0.52; 1.48 ± 0.42. Abdominal aorta: 1.73 ± 0.55; 2.06 ± 1.23; 1.59 ±
0.41; 1.15 ± 0.47. The histopathological aspects of aortas in groups
III and IV were more ﬁbrous than in groups I and II, independently of
vitamin D treatment, however, lower intima/media rate was
observed in the group IV that had received the standard diet and
vitamin D. Conclusion: The normalization of the diet improved the
lipid proﬁle and atherosclerotic plaques in aorta, with beneﬁcial
effect of vitamin D.
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Introduction: The statin class of drugs is the ﬁrst choice in
dyslipidemic patients, to reduction of plasma cholesterol levels,
especially LDL (low density lipoprotein) for the prevention of
cardiovascular disease (CVD). However, fatigue is a side effect in
some patients, possibly by inhibiting melovanato conversion to
coenzyme Q10 (CoQ10), a cofactor in the electron transport chain for
the energy formation, in the same cascade of cholesterol formation.
CoQ10 supplementation helps reduce the effects caused by contin-
uous use of statins. In traditional Chinese Medicine, the Withania
somnifera (or Ashwagandha), is considered an adaptogen herbal and
indicated for fatigue and hipocholesterolemic use. Methods: In this
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